{
      "brief_title": [
            "study",
            "12",
            "month",
            "extension",
            "evaluate",
            "two",
            "investigational",
            "drug",
            "postmenopausal",
            "woman",
            "osteoporosis"
      ],
      "brief_summary": [
            "purpose",
            "study",
            "12",
            "month",
            "extension",
            "evaluate",
            "effect",
            "two",
            "investigational",
            "drug",
            "osteoporosis",
            "postmenopausal",
            "woman"
      ],
      "condition": [
            "postmenopausal"
      ],
      "intervention_type": [
            "Drug",
            "Drug"
      ],
      "intervention_name": [
            "MK0217, alendronate sodium/Duration of Intervention: 12 mo",
            "Comparator: risedronate / Duration of Intervention: 12 mo"
      ],
      "criteria": [
            "inclusion",
            "criterion",
            "postmenopausal",
            "woman",
            "osteoporosis",
            "exclusion",
            "criterion",
            "know",
            "allergy",
            "study",
            "drug"
      ],
      "gender": "Female",
      "minimum_age": [
            "40",
            "year"
      ],
      "maximum_age": [],
      "healthy_volunteers": "No",
      "mesh_term": [
            "postmenopausal",
            "sodium"
      ],
      "id": "NCT00092040"
}